Doctor Sylwia Wisniowska-Smialek
Jagiellonian University Medical College, John Paul II Hospital, Krakow (Poland)
Follow
Contributor content
Presentation
Differences in clinical, morphological and laboratory parameters between hypertrophic cardiomyopathy patients with and without heart failure
Presentation
12 month kinetic of fibrosis assessed with cardiac magnetic resonance in dilated cardiomyopathy patients with different etiology
Presentation
Relationships between 18-month kinetics and functional capacity and left ventricular remodeling and cardiac fibrosis in dilated cardiomyopathy
Presentation
Clinical characteristic of LVAD recipients required over and lower than median dosage of loop diuretic during 12 month following the implantation
Presentation
Free triiodothyronine/free thyroxine ratio as a predictor of mortality in LVAD recipients during 12 months of observations
Presentation
18-month pattern of cardiac-specific biomarkers and replacement and interstitial fibrosis in dilated cardiomyopathy
Presentation
Comparison of COVID-19 clinical course between LVAD recipients implanted before and during COVID-19 pandemic.
Presentation
Are there differences in 6-month outcomes between LVAD recipients during pre-COVID-19 and COVID-19 era?
Presentation
Presentation
